| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 4 | 10 | 41 | | Cost of Revenue | 125 | 135 | 143 | | | Gross Profit | (121) | (125) | (102) | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 425 | 513 | 536 | | Non Recurring |
-
| 53 | 1,018 | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (546) | (690) | (1,656) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| | Earnings Before Interest And Taxes | (546) | (690) | (1,656) | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | (546) | (690) | (1,656) | | Income Tax Expense |
-
|
-
| (35) | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (546) | (690) | (1,621) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (546) | (690) | (1,621) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($546) | ($690) | ($1,621) |
|
1.48% Nasdaq 
Income Statement
